Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis B. Issue 2 (March 2009)

• Record Type: Journal Article
• Authors: Potter, Martin; Klein, Marina B
• Is Part Of: HIV therapy. Volume 3:Issue 2(2009)
• Page Start: 189
• Page End: 207
• Publication Date: 2009-03
• Subjects: co-infection -- HAART -- HBV -- HCV -- HIV/AIDS -- liver disease -- nucleoside analogs -- ribavirin; HIV (Viruses) -- Treatment -- Periodicals; HIV (Viruses) -- Research -- Periodicals; 616.979206
• DOI: 10.2217/17584310.3.2.189
• Languages: English
• ISSNs: 1758-4310

Abstract

An increasing number of people are chronically infected with HIV and HCV, and/or HBV owing to shared routes of transmission. With the advent of HAART, liver disease secondary to hepatitis co-infections has emerged as a leading cause of morbidity and mortality in HIV-infected persons. There is increasing need to manage dual infection, but treatment is complicated by co-morbidities, overlapping toxicities, drug activities and resistance. A model of treatment that builds on the lessons learned from the treatment of HIV has evolved to maximize success of treating dual infections. This review will address current strategies for the management of HIV in the setting of HCV and HBV co-infection and discuss future treatment directions and challenges.